These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 35043593)

  • 1. Risk factors and abnormal cerebrospinal fluid associate with cognitive symptoms after mild COVID-19.
    Apple AC; Oddi A; Peluso MJ; Asken BM; Henrich TJ; Kelly JD; Pleasure SJ; Deeks SG; Allen IE; Martin JN; Ndhlovu LC; Miller BL; Stephens ML; Hellmuth J
    Ann Clin Transl Neurol; 2022 Feb; 9(2):221-226. PubMed ID: 35043593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Longitudinal Study of COVID-19 Sequelae and Immunity: Baseline Findings.
    Sneller MC; Liang CJ; Marques AR; Chung JY; Shanbhag SM; Fontana JR; Raza H; Okeke O; Dewar RL; Higgins BP; Tolstenko K; Kwan RW; Gittens KR; Seamon CA; McCormack G; Shaw JS; Okpali GM; Law M; Trihemasava K; Kennedy BD; Shi V; Justement JS; Buckner CM; Blazkova J; Moir S; Chun TW; Lane HC
    Ann Intern Med; 2022 Jul; 175(7):969-979. PubMed ID: 35605238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors for post-acute sequelae of COVID-19: Survey results from a tertiary care hospital.
    Munipalli B; Ma Y; Li Z; Ganesh R; Knight D; Logvinov II; Paul SN; Delaney TR; Abu Dabrh AM
    J Investig Med; 2023 Dec; 71(8):896-906. PubMed ID: 37485961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebrospinal fluid metabolomic and proteomic characterization of neurologic post-acute sequelae of SARS-CoV-2 infection.
    Chen S; Liang J; Chen D; Huang Q; Sun K; Zhong Y; Lin B; Kong J; Sun J; Gong C; Wang J; Gao Y; Zhang Q; Sun H
    Brain Behav Immun; 2024 Jan; 115():209-222. PubMed ID: 37858739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Population-Based Estimates of Post-acute Sequelae of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection (PASC) Prevalence and Characteristics.
    Hirschtick JL; Titus AR; Slocum E; Power LE; Hirschtick RE; Elliott MR; McKane P; Fleischer NL
    Clin Infect Dis; 2021 Dec; 73(11):2055-2064. PubMed ID: 34007978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic Disease Self-Management of Post-Acute Sequelae of COVID-19 Among Older Adults: A Mixed-Methods Analysis.
    Thomas-Purcell K; Davenport R; Ayala V; Purcell D; Ownby RL
    Clin Interv Aging; 2023; 18():607-617. PubMed ID: 37082741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma Biomarkers of Neuropathogenesis in Hospitalized Patients With COVID-19 and Those With Postacute Sequelae of SARS-CoV-2 Infection.
    Hanson BA; Visvabharathy L; Ali ST; Kang AK; Patel TR; Clark JR; Lim PH; Orban ZS; Hwang SS; Mattoon D; Batra A; Liotta EM; Koralnik IJ
    Neurol Neuroimmunol Neuroinflamm; 2022 May; 9(3):. PubMed ID: 35256481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Next-Generation Sequencing and Proteomics of Cerebrospinal Fluid From COVID-19 Patients With Neurological Manifestations.
    Wang H; Zhang Z; Zhou J; Han S; Kang Z; Chuang H; Fan H; Zhao H; Wang L; Ning Y; Sarapultsev A; Li WX; Li J; Lin Z; Luo S; Xiong N; Hu D
    Front Immunol; 2021; 12():782731. PubMed ID: 34956212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persistence of SARS CoV-2 S1 Protein in CD16+ Monocytes in Post-Acute Sequelae of COVID-19 (PASC) up to 15 Months Post-Infection.
    Patterson BK; Francisco EB; Yogendra R; Long E; Pise A; Rodrigues H; Hall E; Herrera M; Parikh P; Guevara-Coto J; Triche TJ; Scott P; Hekmati S; Maglinte D; Chang X; Mora-Rodríguez RA; Mora J
    Front Immunol; 2021; 12():746021. PubMed ID: 35082777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pre-existing conditions associated with post-acute sequelae of COVID-19.
    Jacobs ET; Catalfamo CJ; Colombo PM; Khan SM; Austhof E; Cordova-Marks F; Ernst KC; Farland LV; Pogreba-Brown K
    J Autoimmun; 2023 Feb; 135():102991. PubMed ID: 36634460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurological post-acute sequelae of SARS-CoV-2 infection.
    Takao M; Ohira M
    Psychiatry Clin Neurosci; 2023 Feb; 77(2):72-83. PubMed ID: 36148558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Large and Small Cerebral Vessel Involvement in Severe COVID-19: Detailed Clinical Workup of a Case Series.
    Keller E; Brandi G; Winklhofer S; Imbach LL; Kirschenbaum D; Frontzek K; Steiger P; Dietler S; Haeberlin M; Willms J; Porta F; Waeckerlin A; Huber M; Abela IA; Lutterotti A; Stippich C; Globas C; Varga Z; Jelcic I
    Stroke; 2020 Dec; 51(12):3719-3722. PubMed ID: 33054673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COVID-19-associated Guillain-Barre syndrome: Postinfectious alone or neuroinvasive too?
    Khan F; Sharma P; Pandey S; Sharma D; V V; Kumar N; Shukla S; Dandu H; Jain A; Garg RK; Malhotra HS
    J Med Virol; 2021 Oct; 93(10):6045-6049. PubMed ID: 34170552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Longitudinal evaluation of neurologic-post acute sequelae SARS-CoV-2 infection symptoms.
    Shanley JE; Valenciano AF; Timmons G; Miner AE; Kakarla V; Rempe T; Yang JH; Gooding A; Norman MA; Banks SJ; Ritter ML; Ellis RJ; Horton L; Graves JS
    Ann Clin Transl Neurol; 2022 Jul; 9(7):995-1010. PubMed ID: 35702954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors Associated with Post-Acute Sequelae of SARS-CoV-2 (PASC) After Diagnosis of Symptomatic COVID-19 in the Inpatient and Outpatient Setting in a Diverse Cohort.
    Yoo SM; Liu TC; Motwani Y; Sim MS; Viswanathan N; Samras N; Hsu F; Wenger NS
    J Gen Intern Med; 2022 Jun; 37(8):1988-1995. PubMed ID: 35391623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The kynurenine pathway relates to post-acute COVID-19 objective cognitive impairment and PASC.
    Cysique LA; Jakabek D; Bracken SG; Allen-Davidian Y; Heng B; Chow S; Dehhaghi M; Staats Pires A; Darley DR; Byrne A; Phetsouphanh C; Kelleher A; Dore GJ; Matthews GV; Guillemin GJ; Brew BJ
    Ann Clin Transl Neurol; 2023 Aug; 10(8):1338-1352. PubMed ID: 37318955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molnupiravir and risk of post-acute sequelae of covid-19: cohort study.
    Xie Y; Choi T; Al-Aly Z
    BMJ; 2023 Apr; 381():e074572. PubMed ID: 37161995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [SARS-CoV-2 Detection in cerebrospinal fluid in a pediatric patient. Case report].
    Franco P; Bellesi Y; Nocent E; Strappa A; Galeano ML;
    Arch Argent Pediatr; 2021 Feb; 119(1):e58-e60. PubMed ID: 33458993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New-onset and persistent neurological and psychiatric sequelae of COVID-19 compared to influenza: A retrospective cohort study in a large New York City healthcare network.
    Iosifescu AL; Hoogenboom WS; Buczek AJ; Fleysher R; Duong TQ
    Int J Methods Psychiatr Res; 2022 Sep; 31(3):e1914. PubMed ID: 35706352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deep Phenotyping of Neurologic Postacute Sequelae of SARS-CoV-2 Infection.
    Mina Y; Enose-Akahata Y; Hammoud DA; Videckis AJ; Narpala SR; O'Connell SE; Carroll R; Lin BC; McMahan CC; Nair G; Reoma LB; McDermott AB; Walitt B; Jacobson S; Goldstein DS; Smith BR; Nath A
    Neurol Neuroimmunol Neuroinflamm; 2023 Jul; 10(4):. PubMed ID: 37147136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.